Guggenheim Securities’ Vamil Divan breaks down Merck’s inventory drop

Share

Vamil Divan, Guggenheim Securities biopharmaceutical analyst, joins ‘Energy Lunch’ to debate Merck’s troubles in China.

02:46

an hour in the past

Supply hyperlink

Leave a Comment